Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Galvus
| Field | Information |
|---|---|
| Medication Name | Galvus |
| Generic Name | Vildagliptin |
| Purpose | Used to treat type 2 diabetes mellitus |
| Mechanism of Action | Inhibits dipeptidyl peptidase-4 (DPP-4), increasing incretin levels and stimulating insulin release while decreasing glucagon secretion |
| Dosage Forms | Oral tablets |
| Available Strengths | 50 mg |
| Dosage Frequency | Typically once or twice daily, as directed by a healthcare provider |
| Common Side Effects | Headache, nausea, dizziness, upper respiratory tract infection |
| Serious Side Effects | Pancreatitis, liver problems, severe allergic reactions (rare) |
| Drug Interactions | Insulin secretagogues (e.g., sulfonylureas), insulin, other antidiabetic medications |
| Important Notes | Monitor blood sugar regularly; consult a doctor if you experience persistent abdominal pain or yellowing of skin/eyes |
| Storage | Store at room temperature away from moisture and light |
| Missed Dose | Take as soon as you remember; skip if it’s almost time for your next dose. Do not double the dose. |
| Alternatives | Metformin, Glipizide, Sitagliptin (Januvia), Empagliflozin (Jardiance) |
Galvus Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Metformin (Glucophage) | Decreases hepatic glucose production and increases insulin sensitivity | First-line treatment for type 2 diabetes. |
| Glipizide (Glucotrol) | Stimulates insulin release from the pancreas | Sulfonylurea; use with caution due to hypoglycemia risk. |
| Sitagliptin (Januvia) | DPP-4 inhibitor, similar to vildagliptin | May be an alternative if Galvus is not tolerated. |
| Empagliflozin (Jardiance) | SGLT2 inhibitor, increases glucose excretion in urine | May offer cardiovascular benefits. |
Galvus Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Headache | Pancreatitis (severe abdominal pain, nausea, vomiting) |
| Nausea | Liver problems (yellowing of skin/eyes, dark urine, fatigue) |
| Dizziness | Severe allergic reactions (rash, itching, swelling, difficulty breathing) |
| Upper respiratory tract infection | Joint pain (arthralgia) |
| Peripheral edema (swelling of ankles/feet) | Bullous pemphigoid (blistering skin condition) |
Galvus Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Type 2 Diabetes Mellitus | 50 mg once daily | 50 mg once or twice daily; maximum 100 mg daily | Take with or without food. If taking 100mg daily, divide into two 50mg doses, one in the morning and one in the evening. |
Galvus Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $25 |
| Without Insurance (U.S.) | $250 |
| From Canada | $180 |
